To compare pramipexole to escitalopram in the treatment of major depressive disorder in people living with HIV.
The purpose of this research study is to evaluate the safety and efficacy of pramipexole extended release (ER) versus escitalopram for the treatment of major depressive disorder (MDD) and mild neurocognitive disorder (MND) in people living with HIV (PWH).
Individuals living with HIV and with a diagnosis of major depressive disorder
Principal Investigator